TAURINE IN HEALTH AND DISEASES: CONSISTENT EVIDENCE FROM EXPERIMENTAL AND EPIDEMIOLOGICAL STUDIES

Taurine (T) was first noted as beneficial for stroke and cardiovascular diseases (CVD) prevention in genetic rat models, stroke-prone spontaneously hypertensive rats (SHRSP). The preventive mechanisms of T were ascribed to sympathetic modulation for reducing blood pressure (BP) and antiinflammatory action. Recent epidemiological surveys revealed the involvement of inflammatory mediators in the pathogenesis of stroke and also atherosclerosis for which T was proven to be effective experimentally. Arterio-lipidosis prone rats, a substrain of SHRSP selectively bred for higher reactive hypercholesterolemia, quickly develop not only arterial fat deposition but also fatty liver which could be attenuated by dietary T supplementation. CARDIAC (CVD and Alimentary Comparison) Study was a WHO-coordinated multi-center epidemiological survey on diets and CVD risks and mortalities in 61 populations. Twenty-four-hour urinary (24U) T was inversely related significantly with coronary heart disease mortality. Higher 24U-T excreters had significantly lower body mass index, systolic and diastolic BP, total cholesterol (T-Cho), and atherogenic index (AI: T-Cho/high density lipoprotein-cholesterol) than lower T excreters. T effects on CVD risks were intensified in individuals whose 24U-T and -magnesium (M) excretions were higher. Furthermore, higher Na excreters with higher heart rate whose BP were significantly higher than those with lower heart rate were divided into two groups by the mean of 24U-T, high and low T excreters. Since the former showed significantly lower BP than the latter, T may beneficially affect salt-sensitive BP rise. Included among the typical 61 populations, were Guiyang, China or St. John’s, Newfoundland, Canada, in which the means of both 24U-T and -M were high or low, respectively. The former and the latter had low and high CVD risks, respectively. Australian Aboriginals living at the coastal area in Victoria were supposed to eat T- and M-rich bush and sea foods and be free from CVD 200 years ago, but they presently have nearly the highest CVD risks indicating that T- and/or M-containing seafood, vegetables, fruits, nuts, milk, etc, similar to prehistoric hunters’ and gatherers’ food should be good for CVD prevention. The preventive effects of T, good for health and longevity, first noted experimentally, were also proven epidemiologically in humans.

1. Okamoto K, Aoki K: Development of a strain of spontaneously hypertensive rats. Jpn Circ J 1963, 27:282-293.

2. Yamori Y: Development of the spontaneously hypertensive rat (SHR) and of various spontaneous rat models, and their implications. Handbook of Hypertension Elsevierde Jong W. Amsterdam 1984, 224-239.

3. Okamoto T, Yamori Y, Nagaoka A: Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res 1974, 34/35:143- 153.

4. Yamori Y: The stroke-prone spontaneously hypertensive rat: Contribution to risk factor analysis and prevention of hypertensive diseases. Handbook of Hypertension Elsevierde Jong W. Amsterdam 1984, 240-255.

5. WHO and WHO Collaborating Centers: CARDIAC (Cardiovascular Diseases and Alimentary Comparison) study protocol. Shimane/ Geneva 1986.

6. Yamori Y: Hypertension and biological dietary markers in urine and blood: A progress report from the CARDIAC study group. New Horizons in Preventing Cardiovascular Diseases ElsevierYamori Y, Strasser T. Amsterdam 1989, 111-126.

7. Yamori Y, Nara Y, Mizushima S, Murakami S, Ikeda K, Sawamura M, Nabika T, Horie R: Gene-environment interaction in hypertension, stroke and atherosclerosis in experimental models and supportive findings from a world-wide cross-sectional epidemiological survey: a WHO-CARDIAC study. Clin Exp Pharmacol Physiol Suppl 1992, 20:43-52.

8. Yamori Y, Liu L, Mizushima S, Ikeda K, Nara Y: Male cardiovascular mortality and dietary markers in 25 population samples of 16 countries. J Hypertens 2006, 24:1499-1505.

9. Nara Y, Yamori Y, Lovenberg W: Effect of dietary taurine on blood pressure in spontaneously hypertensive rats. Biochem Pharmacol 1978, 27:2689-2692.

10. Yamori Y, Nara Y, Ikeda K, Mizushima S: Is taurine a preventive nutritional factor of cardiovascular diseases or just a biological marker of nutrition? Adv Exp Med Biol 1996, 403:623-629.

11. Yamori Y, Liu L, Ikeda K, Miura A, Mizushima S, Miki T, Nara Y: Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hypertens Res 2001, 24:453-457.

12. Yamori Y, Liu L, Mori M, Sagara M, Murakami S, Nara Y, Mizushima S: Taurine as the nutritional factor for the longevity of the Japanese revealed by a world-wide epidemiological survey. Adv Exp Med Biol 2009, 643:13-25.

13. Chen SW, Chen YX, Shi J, Lin Y, Xie WF: The restorative effect of taurine on experimental nonalcoholic steatohepatitis. Dig Dis Sci 2006, 51:2225-2234.

14. Yamori Y, Taguchi T, Mori M, Mori H: Low cardiovascular risks in the middle aged males and females excreting greater 24-hour urinary taurine and magnesium in 41 WHO-CARDIAC study populations in the world. J Biomed Sci., Citation from within the same Supplement.

15. Yamori Y: Predictive and preventive pathology of cardiovascular diseases. Acta Pathol Jpn 1989, 39:683-705.

16. Yamori Y, Horie R, Nara Y, Tagami M, Kihara M, Mano M, Ishio H: Pathogenesis and dietary prevention of cerebrovascular diseases in animal models and epidemiological evidence for the applicability in man. Prevention of Cardiovascular Diseases, an Approach to Active Long Life ElsevierYamori Y, Lenfant C. Amsterdam 1987, 163-177.

17. Tagami M, Tsukada T, Kubota A, Nara A, Yamori Y: Immunocytochemical study of cerebral perforating arteries in patients with cerebral infactions. Acta Histochem Cytochem 1993, 26:109-115.

18. Schuller Levis GB, Park E: Taurine and its chloramine: modulators of immunity. Neurochem Res 2004, 29:117-126.

19. Sun Jang J, Piao S, Cha YN, Kim C: Taurine chloramine activates Nrf2, increases HO-1 expression and protects cells from death caused by hydrogen peroxide. J Clin Biochem Nutr 2009, 45:37-43.

20. Alexander RW: Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995, 25:155-161.

21. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347:1557-1565.

22. Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, Chambless LE, Myerson M, Wu KK, Sharrett AR, Boerwinkle E: Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middleaged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med 2005, 165:2479-2484.

23. Ouellet V, Weisnagel SJ, Marois J, Bergeron J, Julien P, Gougeon R, Tchernof A, Holub BJ, Jacques H: Dietary cod protein reduces plasma Creactive protein in insulin-resistant men and women. J Nutr 2008, 138:2386-2391.

24. Yamori Y, Hamashima Y, Horie R, Handa H, Sato M: Pathogenesis of acute arterial fat deposition in spontaneously hypertensive rats. Jpn Circ J 1975, 39:601-609.

25. Yamori Y, Horie R, Sato M, Fukase M: Hypertension as an important factor for cerebrovascular atherogenesis in rats. Stroke 1976, 7:120-125.

26. Murakami S, Yamagishi I, Asami Y, Ohta Y, Toda Y, Nara Y, Yamori Y: Hypolipidemic effect of taurine in stroke-prone spontaneously hypertensive rats. Pharmacology 1996, 52:303- 313.

27. Murakami S, Nara Y, Yamori Y: Taurine accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats. Life Sci 1996, 58:1643-1651.

28. Mizushima S, Nara Y, Sawamura M, Yamori Y: Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv Exp Med Biol 1996, 403:615-622.

29. Yokogoshi H, Mochizuki H, Nanami K, Hida Y, Miyachi F, Oda H: Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J Nutr 1999, 129:1705-1712.

30. Murakami S, Kondo Y, Toda Y, Kitajima H, Kameo K, Sakono M, Fukuda N: Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci 2002, 70:2355-2366.

31. Yamori Y, Murakami S, Nara Y: Activated acyl coenzyme A-cholesterol acyltransferase as a possible cause of rapid arterial fat deposition in genetic hypertensive rat models for atherosclerosis. J Vasc Med Biol 1991, 3:268-270.

32. Nakano A, Inoue N, Sato Y, Nishimichi N, Takikawa K, Fujita Y, Kakino A, Otsui K, Yamaguchi S, Matsuda H, Sawamura T: LOX-1 mediates vascular lipid retention under hypertensive state. J Hypertens 2000.

33. Chiba Y, Ando K, Fujita T: The protective effects of taurine against renal damage by salt loading in Dahl salt-sensitive rats. J Hypertens 2002, 20:2269-2274.

34. Wang LJ, Yu YH, Zhang LG, Wang Y, Niu N, Li Q, Guo LM: Taurine rescues vascular endothelial dysfunction in streptozocininduced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas. Eur J Pharmacol 2008, 597:75-80.

35. Kitamori K, Kobayashi M, Tsuchikura S, Hiraoka-Yamamoto J, Yasui N, Nara Y, Ikeda K, Yamori Y, Nakajima T: High fat dietinduced liver injury and lipid metabolic disorder in arteriolipidosisprone rat (ALR) [abstract]. Proceedings of the 2nd International Symposium on Lifestyle Related Diseases 2006, 33.

36. Yamori Y, Murakami S, Nara Y, Ikeda K: Stroke-prone SHR and arteriolipidosis-prone SHR as models for atherosclerosis: their mechanisms and application for nutritional and pharmacological studies. Clin Exp Pharmacol Physiol Suppl 1995, 22: S244-245.

37. Yamori Y: Food factors for atherosclerosis prevention: Asian perspective derived from analyses of worldwide dietary biomarkers. Exp Clin Cardiol 2006, 11:94-98.

38. Yamori Y: Food culture: Development and Education. Paris: UNESCO 2009.

39. Yamori Y, Liu L, Ikeda K, Mizushima S, Nara Y, Simpson FO: Different associations of blood pressure with 24-hour urinary sodium excretion among pre- and post-menopausal women. WHO Cardiovascular Diseases and Alimentary Comparison (WHO-CARDIAC) Study. J Hypertens 2001, 19:535-538.

40. Liu L, Mizushima S, Ikeda K, Nara Y, Yamori Y: Resting heart rate in relation to blood pressure: Results from the World Health Organization- Cardiovascular Disease and Alimentary Comparison Study. Int J Cardiol 2000.